PER 1.27% 8.0¢ percheron therapeutics limited

Ann: Change of Director's Interest Notice (MD, page-20

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,566 Posts.
    re: Ann: Change of Director's Interest No... Your point is valid Kippax, the first paragraph of your post is spot-on-in an ideal world, we know that we don't live in one of those. Anyway, about the free/cheap shares the MD/MD still has to perform in order to 'add value' to them and I think sometimes is a better way forward than straight cash remuneration, especially with a micro-bio like ANP. He has a vested interest (as we all do as shareholders) in overseeing a successful transition from research activities to eventual commercialisation. So far, ticks and kudos from me in this regard. Some here seek perfection, well I've got news for them. That does not occur in any form in this life.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.